Injeq

Injeq operates in the medical technology sector, specializing in the development and commercialization of advanced spinal needles. The company's flagship product, the Injeq spinal needle, utilizes pioneering tissue identification technology to enhance the precision and safety of lumbar punctures. This technology is particularly beneficial in emergency rooms where quick and accurate diagnoses are critical. Injeq serves healthcare professionals, including seasoned medical practitioners and recent graduates, who perform lumbar puncture procedures. The company's market includes hospitals and medical institutions that require high-precision medical tools to improve patient outcomes. Injeq's business model revolves around the sale of its innovative spinal needles, generating revenue through direct sales to healthcare providers and institutions. The company aims to reduce trauma and bleeding during lumbar punctures, especially in newborns and children, thereby improving the success rate of these procedures. Key features of the Injeq spinal needle include an audio alarm that alerts physicians when spinal fluid is reached, ensuring accurate needle placement. This product is the result of over a decade of research, innovation, and field studies, backed by top medical expertise.

Keywords: spinal needle, tissue identification, lumbar puncture, medical technology, healthcare, precision, safety, innovation, emergency room, pediatric care.